Quinazoline-1-deoxynojirimycin hybrids as high active dual inhibitors of EGFR and α-glucosidase
- 1 September 2017
- journal article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 27 (18) , 4309-4313
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (21272144)
- Fundamental Research Funds
- Universities of Shaanxi Normal University (X2015YB06)
This publication has 40 references indexed in Scilit:
- 2. Classification and Diagnosis of DiabetesDiabetes Care, 2016
- Alpha-glucosidase inhibitors and hepatotoxicity in type 2 diabetes: a systematic review and meta-analysisScientific Reports, 2016
- Treatment of Type 2 Diabetes: From “Guidelines” to “Position Statements” and BackDiabetes Care, 2016
- Diabetes mellitus – Definition, Klassifikation und DiagnoseWiener klinische Wochenschrift, 2016
- Mechanism of Metformin: A Tale of Two SitesDiabetes Care, 2016
- 4. Prevention or Delay of Type 2 DiabetesDiabetes Care, 2015
- The association of diabetes mellitus with liver, colon, lung, and prostate cancer is independent of hypertension, hyperlipidemia, and gout in Taiwanese patientsMetabolism, 2012
- Diabetes and CancerDiabetes Care, 2010
- ThiazolidinedionesDiabetes Care, 2005
- Diabetic Ketoacidosis Associated With Orlistat TreatmentDiabetes Care, 2001